Loading candles…
Dr. Lal PathLabs Limited is a healthcare company in India with a history of over 75 years. It operates in the consumer healthcare, diagnostic services, and healthcare industries. The company provides diagnostic and related healthcare tests, including pathology and radiology tests and core testing services. Its offerings support patient diagnosis, prevention, monitoring, and treatment of diseases and other health conditions. Dr. Lal PathLabs serves individual patients, hospitals, healthcare providers, and corporate clients through an integrated nationwide network. No information on incorporation details, founders, key management, subsidiaries, or stock listings is available.
This page is a live market overview for DR. LAL PATH LABS LTD. (LALPATHLAB) on the NSE. As a listed security, DR. LAL PATH LABS LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for LALPATHLAB before placing trades on tick2trade.
As of the latest feed, LALPATHLAB last traded at ₹1,931.6 on NSE, up ₹3.6 (0.19%) from the previous close of ₹1,928. Today's session range is ₹1,907.1 – ₹1,947.9, against a 52-week band of ₹1,272.6 – ₹1,955.1. Traded volume today stands at 1.58L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for LALPATHLAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether LALPATHLAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for DR. LAL PATH LABS LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in LALPATHLAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated LALPATHLAB option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ending Jun 30, 2026 and other business mattersPlease note that this Board Meeting pertains to th… | 24 Jul 2026 |
| Dividend | To consider Interim dividend for FY 2026-27, if any, | 24 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 30 Apr 2026 |
| Dividend | To consider and recommend Final Dividend for FY 2025-26, if any | 30 Apr 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 30 Jan 2026 |
| Dividend | To consider 3rd Interim dividend, if any for FY 2025-26 | 30 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025, dividend and other business matters | 31 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters | 25 Apr 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.